The Truth About Type 2 Diabetes — What Most Will County Patients Haven’t Been Told
Type 2 diabetes is often described as a chronic, progressive condition that patients manage for life with increasing medication. That framing is accurate for patients at certain stages of the disease. What it misses is the equally well-supported evidence that type 2 diabetes caught early — and in many cases even after it has been diagnosed — is a condition that can be meaningfully reversed, not just managed. The distinction between those two frameworks produces very different patient behaviors.
At Primary Care Joliet, serving Will County with locations in Joliet and Wilmington, the team approaches type 2 diabetes with the comprehensive, educational primary care model that makes the most consequential health decisions more informed. Here’s the accurate picture.
The Numbers Are Larger Than Most People Realize
Approximately 37 million Americans have type 2 diabetes. Another 96 million — roughly one in three adults — have prediabetes: blood glucose levels that are elevated above normal but not yet in the diabetic range. Prediabetes typically produces no symptoms. Most people who have it don’t know.
This is the most clinically significant part of the type 2 diabetes picture: the window in which intervention is most effective — when blood glucose is elevated but the insulin-producing beta cells of the pancreas haven’t yet been significantly impaired — is also the window when no symptoms alert the patient to act. The diagnosis of prediabetes is made only when someone gets a blood test that includes glucose or HbA1c measurement.
Without that test, prediabetes often goes undetected until it has progressed to type 2 diabetes. Without intervention at the prediabetes stage, the likelihood of progression to type 2 diabetes over ten years is approximately 37 percent.
What Actually Causes Type 2 Diabetes
Type 2 diabetes develops from a combination of insulin resistance and progressive impairment of beta cell function. Insulin resistance — the reduced ability of muscle, liver, and fat cells to respond to insulin’s signal to take up glucose — typically develops years before diagnosis, driven by excess body fat (particularly visceral fat), physical inactivity, chronic inflammation, and genetic susceptibility.
As insulin resistance increases, the pancreas compensates by producing more insulin. This compensation can maintain near-normal blood glucose for years. When the pancreatic capacity to compensate is exceeded — either because resistance increases further or because beta cell function declines — blood glucose rises into the prediabetic and then diabetic range.
The reason early intervention is so powerful is that insulin resistance is substantially reversible with the right lifestyle interventions, and beta cell function that has not been significantly impaired can recover with that reversal.
The Evidence for Remission — and What It Requires
The word “remission” in the context of type 2 diabetes means blood glucose returning to below-diabetic levels without active medication — not a complete elimination of the underlying predisposition, but a reversal of the active disease to a non-diabetic state.
Multiple large clinical trials — including the Diabetes Remission Clinical Trial (DiRECT) — have demonstrated remission rates of 36 to 46 percent at two years with intensive lifestyle intervention, primarily centered on significant dietary caloric restriction and weight loss. The DiRECT trial showed that approximately half of patients who achieved 15 kilograms or more of weight loss achieved remission — a result that most patients would not have predicted from a condition described as inevitably progressive.
These results are not achievable at every stage of the disease. Patients who have had type 2 diabetes for many years, who have significant beta cell impairment, or who have specific comorbidities face different outcomes. But for newly diagnosed patients and those in the prediabetic range, the evidence for meaningful reversal through lifestyle intervention is stronger than most patients — and some clinicians — have been told.
The Role of Medication — When It’s Necessary and When It’s Supportive
Medication for type 2 diabetes — metformin as the standard first-line agent, GLP-1 receptor agonists (semaglutide, tirzepatide) for patients with cardiovascular risk or significant obesity, SGLT-2 inhibitors, and others — is appropriate and evidence-based for patients whose blood glucose cannot be adequately controlled with lifestyle measures alone, or for whom the urgency of glucose control requires medication alongside lifestyle change.
GLP-1 receptor agonists in particular have transformed diabetes management by producing significant weight loss alongside glucose control — addressing the primary driver of insulin resistance while managing the disease.
The Primary Care Joliet team helps each patient understand where they are in the disease spectrum and what combination of lifestyle and medical management is most likely to produce the outcome they want — including, for appropriate patients, the conversation about remission as a specific goal.
The Annual Physical as the Detection Tool
The HbA1c blood test — which reflects average blood glucose over the prior two to three months — is the most reliable screening tool for both prediabetes and type 2 diabetes. It’s a standard component of a comprehensive metabolic panel that can be ordered at a routine annual physical.
The patients who are diagnosed with prediabetes at a meaningful stage — early enough for lifestyle intervention to produce the most significant impact — are those who maintained regular primary care relationships and had their bloodwork assessed consistently. The patients who present with type 2 diabetes diagnosed at the point of symptoms (excessive thirst, urination, fatigue) have typically been in the prediabetic range for years without detection.
At Primary Care Joliet, the annual physical and the bloodwork it includes are the most practically valuable tools available for catching type 2 diabetes in the window when it’s most addressable. The walk-in availability, same-day appointments, and evening and weekend hours exist specifically to remove the barriers that keep busy Will County patients from maintaining the primary care relationship that makes early detection possible.
Schedule Your Appointment at Primary Care Joliet
Primary Care Joliet serves Will County with walk-in availability, same-day appointments, and evening and weekend hours at our locations in Joliet and Wilmington. Call (815) 726-2200 to schedule your appointment. If your blood glucose has been elevated, if you’ve been told you have prediabetes, or if you have type 2 diabetes and haven’t had a comprehensive conversation about what remission might mean for your specific situation — this is the practice where that conversation can happen.
This blog is educational. Diabetes management should always be supervised by a qualified physician. Do not adjust or discontinue any medications without consulting your healthcare provider.
Posted on behalf of